Mo­bile app de­vel­op­er adds dis­ease-spe­cif­ic mod­ules for pa­tients – and phar­ma part­ners

While phar­ma com­pa­nies have strug­gled to gain trac­tion with mo­bile apps for pa­tients, one de­vel­op­er is work­ing on a way to help. Smart­pa­tient is launch­ing dis­ease-spe­cif­ic mod­ules for its MyTher­a­py app — with phar­ma part­ner­ships.

The first add-on, MyTher­a­py MS, de­buted last week with 1,000 mul­ti­ple scle­ro­sis pa­tients al­ready us­ing it through a tri­al in Ger­many. Smart­pa­tient plans to ex­pand the MS mod­ule to Eu­rope and the US lat­er while al­so lin­ing up more dis­ease-spe­cif­ic mod­ules for asth­ma, pso­ri­a­sis, rheuma­toid arthri­tis and HIV for de­but over the next few months.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER